Article Figures & Data
Figures
Additional Files
Data Supplement
- Supplemental Data -
Supplementary Table 1 - Optimized MRM parameters of GSH, CYS, CYS-GLY, γ-GC, [3-13C]GSH, [3-13C]CYS-GLY and internal standard for LC-MS/MS determination.
Supplementary Figure 1 - Migration ratio of hCMEC/D3 at 12h (A) or 24h (B) after treating GSH or BSO. Data are mean ± SD. *P < 0.05, **P < 0.01 and **** P < 0.0001 by unpaired two-tailed Student’s t-test (n=6)
Supplementary Figure 2 - The distribution of CYS in rat tissues after intragastrical administration of GSH at 250mg/kg (A) Plasma (B) Heart, (C) Liver, (D) Kidney, (E) Stomach, (F) Duodenum, (G) Jejunum, (H) Ileum, (I) Colon.
Supplementary Figure 3 - The distribution of CYS-GLY in rat tissues after intragastrical administration of GSH at 250mg/kg. (A) Plasma (B) Heart, (C) Liver, (D) Kidney, (E) Stomach, (F) Duodenum, (G) Jejunum, (H) Ileum, (I) Colon.
Supplementary Figure 4 - The distribution of γ-GC in rat tissues after intragastrical administration of GSH at 250mg/kg. (A) Plasma (B) Heart, (C) Liver, (D) Kidney, (E) Stomach, (F) Duodenum, (G) Jejunum, (H) Ileum, (I) Colon.
Supplementary Figure 5 - The distribution of Glu in rat tissues after intragastrical administration of GSH at 250mg/kg.
(A) Plasma (B) Heart, (C) Liver, (D) Kidney, (E) Stomach, (F) Duodenum, (G) Jejunum, (H) Ileum, (I) Colon.Supplementary Figure 6 - The distribution of GLY in rat tissues after intragastrical administration of GSH at 250mg/kg. (A) Plasma (B) Heart, (C) Liver, (D) Kidney, (E) Stomach, (F) Duodenum, (G) Jejunum, (H) Ileum, (I) Colon.
Supplementary Figure 7 - The mRNA relative expression of GCLc in the rat liver. Data are mean ± SD. ***P <0.001 by unpaired two-tailed Student’s t-test.
- Supplemental Data -